Hello! I am a bioethicist focusing on the Ethical, Legal and Social Implications of Genetics and Genomics (ELSI). The focus of my work is navigating ethical issues that arise in the application of genomic screening. I used to work in the genetics industry; I am convinced of the need for careful reflection and gathering of evidence to help ensure the upsides of genomics are realized, hence my career redirection towards ELSI work. You can read more on my publications page.

I am currently a member of the faculty in Medicine at Harvard Medical School and Mass General Brigham, and affiliate faculty at the Broad Institute and Harvard’s Center for Bioethics. I direct the Bioethics Initiative at the Broad Institute. I am PI on a project entitled “Identifying strategies to reveal genetic results over the lifespan”, funded by a R00 award from the NHGRI. I am a co-investigator on several other projects, including the PRISM site of the MAGen Consortium and the MGB site of the eMERGE Network. My publications page is organized around my main research interests.

I taught the AI and bioethics course in 2026, and am a guest lecturer on several other Harvard courses.

I am an active member of the Global Alliance for Genomics and Health (GA4GH)’s Regulatory and Ethics Workstream. I led or co-lead the working groups that led to the first international policy for the return of results to research participants, the diversity in datasets policy tool, and the navigating ELSI in newborn sequencing policy tool.

Previously, I worked as a computational biologist and product manager. I was with Fabric Genomics (formerly Omicia), a company bridging the gap between sequencing data and actionable clinical reports. And also at the erstwhile Driver Inc, “The cure for cancer treatment”, who sequenced tumor DNA as one part of an effort to match cancer patients to clinical trials. My doctoral degree is in Systems Biology from the University of Oxford.

Prior to the pandemic, I was blogging round-ups of genomics developments at All The Coolest Genomics.

Twitter: @acflewis